BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2445949)

  • 21. Comparison of the anti-inflammatory activity and gastrointestinal irritancy of nabumetone, ibuprofen, and diclofenac in rats following chronic administration.
    Melarange R; Blower P; Spangler R
    Eur J Rheumatol Inflamm; 1994; 14(2):23-7. PubMed ID: 7744130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of NSAIDs on cryoprobe-induced gastric ulcer healing in rats.
    Tibble J; Sigthorsson G; Caldwell C; Palmer RH; Bjarnason I
    Aliment Pharmacol Ther; 2001 Dec; 15(12):2001-8. PubMed ID: 11736732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of PG production by MDL 035, a new non-steroidal non-acidic anti-inflammatory compound, in rat gastric mucosa and inflammatory exudate.
    Luzzani F; Colombo G; Schiatti P; Selva D; Glässer A
    Pharmacol Res Commun; 1984 Aug; 16(8):755-63. PubMed ID: 6333688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative effects of nabumetone, naproxen, piroxicam, and diclofenac on rat gastric irritancy following acute exposure to OTC non-steroidal anti-inflammatory agents and other gastric irritants.
    Carryl OR; Spangler RS
    Scand J Rheumatol; 1995; 24(6):336-41. PubMed ID: 8610216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nabumetone (BRL 14777, 4-[6-methoxy-2-naphthyl]-butan-2-one): a new anti-inflammatory agent.
    Boyle EA; Freeman PC; Mangan FR; Thomson MJ
    J Pharm Pharmacol; 1982 Sep; 34(9):562-9. PubMed ID: 6127380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in man.
    Bjarnason I; Fehilly B; Smethurst P; Menzies IS; Levi AJ
    Gut; 1991 Mar; 32(3):275-7. PubMed ID: 1901563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pentoxifylline prevents indomethacin induced acute gastric mucosal damage in rats: role of tumour necrosis factor alpha.
    Santucci L; Fiorucci S; Giansanti M; Brunori PM; Di Matteo FM; Morelli A
    Gut; 1994 Jul; 35(7):909-15. PubMed ID: 8063218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The unique pharmacologic profile of nabumetone.
    Blower PR
    J Rheumatol Suppl; 1992 Nov; 36():13-9. PubMed ID: 1474529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-steroidal anti-inflammatory drugs and renal response to exercise: a comparison of indomethacin and nabumetone.
    Olsen NV; Jensen NG; Hansen JM; Christensen NJ; Fogh-Andersen N; Kanstrup IL
    Clin Sci (Lond); 1999 Oct; 97(4):457-65. PubMed ID: 10491346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indomethacin enhances bile salt detergent activity: relevance for NSAIDs-induced gastrointestinal mucosal injury.
    Petruzzelli M; Moschetta A; Renooij W; de Smet MB; Palasciano G; Portincasa P; van Erpecum KJ
    Dig Dis Sci; 2006 Apr; 51(4):766-74. PubMed ID: 16615001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Somatostatin stimulates prostaglandin production by rat gastric epithelial cells in vitro, but is not cytoprotective.
    Romano M; Razandi M; Ivey KJ
    Dig Dis Sci; 1988 Nov; 33(11):1435-40. PubMed ID: 2903014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sucralfate protection against gastrointestinal damage: possible role of prostanoids.
    Ligumsky M; Karmeli F; Rachmilewitz D
    Isr J Med Sci; 1986 Nov; 22(11):801-6. PubMed ID: 3098700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nabumetone. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases.
    Friedel HA; Langtry HD; Buckley MM
    Drugs; 1993 Jan; 45(1):131-56. PubMed ID: 7680981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastric mucosal resistance and prostanoid levels after cimetidine treatment in rats.
    Arakawa T; Satoh H; Fukuda T; Sakuma H; Nakamura H; Kobayashi K
    Digestion; 1988; 41(1):1-8. PubMed ID: 3203823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection by mild irritants against indomethacin-induced gastric mucosal damage in the rat: role of prostaglandin synthesis.
    Ligumsky M; Sestieri M; Karmeli F; Rachmilewitz D
    Isr J Med Sci; 1986 Nov; 22(11):807-11. PubMed ID: 3098701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effects of indomethacin and proglumetacin on 6-oxo-PGF1 alpha released ex vivo by rat gastric mucosa.
    Conti P; Alesse E; Cifone MG
    Int J Tissue React; 1986; 8(1):31-4. PubMed ID: 3512465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of nabumetone and dipyrone on experimentally induced gastric ulcers in rats.
    Yıldırım E; Sağıroğlu O; Kılıç FS; Erol K
    Inflammation; 2013 Apr; 36(2):476-81. PubMed ID: 23129452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of pirazolac on prostanoid synthesis by human gastric mucosa in vitro.
    Tavares IA; Bennett A
    Drugs Exp Clin Res; 1990; 16(1):1-6. PubMed ID: 2115830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acemetacin and indomethacin: differential inhibition of constitutive and inducible cyclo-oxygenases in human gastric mucosa and leucocytes.
    Tavares IA; Bennett A
    Int J Tissue React; 1993; 15(2):49-53. PubMed ID: 8144313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A subchronic study of the effect of etodolac on the gastric mucosal prostaglandin levels in the rat.
    Lee DK; Cohen R; Gilliar J; Mulder B; Smith T
    Agents Actions; 1986 Nov; 19(3-4):228-32. PubMed ID: 2950733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.